Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$294K Sell
3,169
-72
-2% -$6.7K 0.01% 334
2026
Q1
$315K Sell
3,241
-269
-8% -$24.6K 0.01% 313
2025
Q4
$310K Sell
3,510
-30
-0.8% -$2.73K 0.01% 308
2025
Q3
$319K Buy
3,540
+75
+2% +$6.07K 0.01% 302
2025
Q2
$263K Buy
3,465
+600
+21% +$44.5K 0.01% 314
2025
Q1
$204K Buy
+2,865
New +$223K 0.01% 326

Other funds holding SRE

Trilogy Capital's SRE Position: Q2 2026 in Review

Trilogy Capital reduced its Sempra (SRE) stake by 2.2% in Q2 2026, selling an estimated $6.7K and leaving 3,169 shares worth $294K. The position accounts for 0.01% of the portfolio, ranked #334.

Trilogy Capital first reported a position in SRE in Q1 2025 and has held it in 6 quarters since. The position peaked at $319K in Q3 2025. 178 funds tracked by Wall St. Rank hold SRE as of Q2 2026.

  • Trilogy Capital held 3,169 shares of Sempra worth $294K as of Q2 2026.
  • Trilogy Capital sold 72 Sempra shares in Q2 2026, an estimated $6.7K.
  • Sempra made up 0.01% of Trilogy Capital's portfolio in Q2 2026, its #334 holding.
  • Trilogy Capital first reported a position in Sempra in Q1 2025 and has held it in 6 quarters since.
  • Trilogy Capital's Sempra position peaked at $319K in Q3 2025.
  • 178 funds tracked by Wall St. Rank held Sempra as of Q2 2026.

Based on Trilogy Capital's 13F filing for Q2 2026, filed 6 Jul 2026.